Dorian Therapeutics
acquired by Altos LabsYC S18 ↗San Francisco, US · Founded 2018 · 8 employees · 2 known investors
Altos Labs focuses on cell rejuvenation to restore cell health and resilience, with the goal of reversing disease, injury, and associated disabilities. The company translates cell biology research into therapeutic interventions.
Founders & leadership· Y Combinator alumni (S18)
Investors · 2
In the news
- Jeff Bezos-Backed Altos Labs Acquires Dorian Therapeutics, NewLimit Raises $130M for Anti-Aging Therapies | DeepNewz VC | Medialmedial.app · 2025
- Altos Labs buys anti-aging startup Dorian Therapeuticsendpoints.news · 2025
- Dorian Therapeutics Appoints Jeff George to Board of Directorsprnewswire.com · 2021
